Your Search Returned 21 tagged news reports
A dramatic rise in thyroid cancer has resulted from overdiagnosis and treatment of tumors too small to ever cause harm, according to a study that found cases nearly tripled since 1975. The study is the latest to question whether all cancers need
Following a priority review, the FDA has approved Nexavar for the treatment of locally recurrent or metastatic, progressive, DTC that is refractory to radioactive iodine (RAI) treatment. Bayer HealthCare executive committee member and global
Screening of Fukushima residents who were 18 or younger at the time of the 2011 nuclear disaster had found 26 confirmed and 32 suspected cases of thyroid cancer as of Sept. 30, according to the Fukushima Prefectural Government. The number of
But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels.
Contact Information Available for logged-in reporters only Description Abstract #28 (Late Breaking): An open-label, multi-center phase 2 study of the BRAF inhibitor vemurafenib in patients with metastatic or unresectable papillary thyroid cancer (ptc)
Endocrine Surgeon at Jersey Shore, will present at the 2nd World Congress on Thyroid Cancer, taking place July 10 through July 14, 2013 in Toronto, Canada. Dr. Shifrin's oral presentation, entitled Assessment of Molecular Markers on Preoperative FNA
More... 'Obviously it's devastating for anyone to lose their breasts, because it defines us as feminine and female,' she told the Ottowa Sun as she posed for a photo shoot for the website. 'But for me, I embraced it.' Rather than undergoing
Late stage thyroid cancer patients with aggressive disease may benefit from a genetic test, but experts caution that use of this test in early stage patients is inappropriate because it is unlikely to lead to better outcomes. Perelman School of
Celebrities With Thyroid Disorders Dancing-with-the-Stars co-host Brooke Burke-Charvet recently underwent surgery for thyroid cancer, so we were happy to hear that the procedure was a success. COM: Although no one wants a diagnosis of cancer, the
Contact Information Available for logged-in reporters only Description Researchers at Thomas Jefferson University Hospital have shown that age 45 is no longer a useful predictor of negative outcomes in the staging of papillary thyroid cancer patients.